Inactive Ingredient Search for Approved Drug Products

You are Searching: Change and Deletion by Inactive Ingredient Name Beginning with MANNITOL

Quarter Inactive Ingredient Route of Administration Dosage Form Maximum Potency per unit dose Maximum Daily Exposure Status
4514 Q4 2020 MANNITOL ORAL POWDER, FOR SUSPENSION 1196.75 mg MDE Replacement
4514 Q1 2021 MANNITOL ORAL POWDER, FOR SUSPENSION 3590 mg MDE Replacement
4529 Q4 2020 MANNITOL ORAL TROCHE 1035.18 mg MDE Replacement
4529 Q1 2021 MANNITOL ORAL TROCHE 15380 mg MDE Replacement
4541 Q4 2020 MANNITOL SUBLINGUAL TABLET 204.00 mg MDE Replacement
4541 Q1 2021 MANNITOL SUBLINGUAL TABLET 240 mg MDE Replacement

 

 

FDA/Center for Drug Evaluation and Research
Office of Pharmaceutical Quality
Office of Policy for Pharmaceutical Quality
Mailbox for IID corrections IIDUpdate@fda.hhs.gov
Update Frequency: Quarterly

Data Through: January 6, 2021
Database Last Updated: January 21, 2021

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English